Related Experiment Video

Updated: Jun 1, 2026

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

Dedifferentiation rescues senescence of progeria cells but only while pluripotent

Laura J Niedernhofer1, Joseph C Glorioso, Paul D Robbins

  • 1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, 523 Bridgeside Point II, 450 Technology Drive, Pittsburgh, PA 15219, USA. niedlx@upmc.edu

Stem Cell Research & Therapy
|June 7, 2011
PubMed

Insights

Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disease caused by progerin. Induced pluripotent stem cells derived from HGPS patients lose progerin, offering a new model for aging research and drug screening.

Area of Science:

  • Genetics
  • Cell Biology
  • Molecular Biology

Background:

  • Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by premature aging.
  • The disease results from a mutation in the LMNA gene, producing a toxic protein called progerin.
  • Progerin disrupts nuclear structure, affecting cellular processes and genomic stability.

Purpose of the Study:

  • To generate and characterize induced pluripotent stem cells (iPSCs) from HGPS fibroblasts.
  • To investigate the behavior of progerin and senescence phenotypes in HGPS iPSCs.
  • To evaluate the utility of HGPS iPSCs for studying HGPS pathogenesis and developing therapies.

Main Methods:

  • Generation of iPSCs from HGPS patient fibroblasts.
  • Characterization of iPSCs for pluripotency markers.
  • Analysis of progerin expression and senescence markers in iPSCs and their differentiated progeny.

Main Results:

  • Successful generation and characterization of HGPS iPSCs.
  • Progerin expression and senescence phenotypes were absent in HGPS iPSCs.
  • These phenotypes were restored in differentiated cells derived from HGPS iPSCs.

Conclusions:

  • HGPS iPSCs provide a valuable model system for studying the role of progerin in HGPS and aging.
  • The loss of progerin in iPSCs highlights the plasticity of cellular phenotypes.
  • HGPS iPSCs are promising for screening therapeutic strategies to combat HGPS and cellular senescence.

More Related Videos

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency09:07

Chemical Reversion of Conventional Human Pluripotent Stem Cells to a Naïve-like State with Improved Multilineage Differentiation Potency

Published on: June 10, 2018

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...